MELODY GANDHI: Open Payments
NPI 1972123008 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$292 in 9 payments from 7 companies in 2025. Trend: 2023 $592 · 2024 $710 · 2025 $292
Food & beverage: $292
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $116 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| Janssen Biotech, Inc. | 2 | $40 |
| Eisai Inc. | 1 | $34 |
| Invivyd Inc | 1 | $21 |
| Amicus Therapeutics, Inc. | 1 | $17 |
| Chiesi USA, Inc. | 1 | $17 |
Products named: EVENITY, SAPHNELO, Leqembi, PEMGARDA, TREMFYA, POMBILITI, ELFABRIO.
Industry payments across TX — which companies pay providers there.
